MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · Medical and pediatric oncology · 1982

Duration of chemotherapy in childhood acute lymphoblastic leukaemia. The Medical Research Council's Working Party on Leukaemia in Childhood.

Клиническое исследованиеСравнительное исследованиеСтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

In three childhood acute lymphoblastic leukaemia (ALL) therapeutic trials a total of 493 patients still in first remission 18 months or 2 years after starting treatment were randomly allocated to stop treatment or continue to 3 years. Periods of 18 months or 2 years were as effective as 3 years for girls, but for boys 18 months was inferior to 3 years, although there was little difference between 2 and 3 years. These conclusions refer only to the treatment regimens employed in these trials, however, and in view of the rather different results for girls in a later trial and the high testicular and marrow relapse rates in boys, the results must be interpreted cautiously. Disease-free survival 5 years after randomisation to stop or continue treatment was 76% for girls, but only 40% for boys.

Для цитирования: Duration of chemotherapy in childhood acute lymphoblastic leukaemia. The Medical Research Council's Working Party on Leukaemia in Childhood.. Medical and pediatric oncology. 1982.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.